• Explore /
  • Poster
  • / NRG Oncology HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.

NRG Oncology HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.

Abstract Video & Slides Poster

Authors

Stephen Lai

Stephen Yenzen Lai

The University of Texas MD Anderson Cancer Center, Houston, TX

Stephen Yenzen Lai , Pedro A. Torres-Saavedra , Neal E. Dunlap , Beth Michelle Beadle , Steven S. Chang , Rathan M. Subramaniam , Jian Qin Yu , Val J. Lowe , Saad A. Khan , Minh Tam Truong , Diana Bell , Cheng Z. Liu , Nataliya Kovalchuk , Yi Rong , Mohamed E. Abazeed , S. Cheenu Kappadath , Jonathan Harris , Quynh-Thu Le

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04333537

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS6093)

DOI

10.1200/JCO.2021.39.15_suppl.TPS6093

Abstract #

TPS6093

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results.

RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results.

First Author: Mrinal M. Gounder

First Author: Guillermo Garcia-Manero

First Author: Kristine Peregrino Lacuna

First Author: Lilian Tran Gien